Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03907488
Brief Title: Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

First Submitted : April 8, 2019
First Submitted that Met QC Criteria : April 8, 2019
First Posted : April 9, 2019

Last Update Submitted that Met QC Criteria : May 20, 2022
Last Update Posted : May 23, 2022